We performed a retrospective cohort study of nulliparous women undergoing obstetric ultrasound between 14 and 23 weeks with a cervical length greater than 3.0 cm who delivered between 24 and 42 weeks gestation. A 3D volume of the placenta was evaluated. The distance from the placental cord insertion to the placental edge (PCI-D) was obtained using VOCAL software. Demographic, ultrasound and pregnancy outcome information were abstracted. Generalised linear regression and generalised additive models were fitted to explore the associations between PCI-D in relation to demographic and clinical characteristics. Results: 216 pregnancies were included in the analysis. PCI-D did not correlate with maternal age, gestational age at delivery, mode of delivery or 5-minute Apgar score. While not statistically significant, both multigravidity and birth weight Z-score were associated with shorter PCI-D (p=0.08, adjusted model). Low-lying placenta or placenta previa was associated with greater PCI-D (p=0.03).
3 Federal University of Rio Grande do Sul, Porto Alegre, Brazil Objectives: To estimate the correlation between two forms of ultrasound measurement of VAT and the fasting glycemic levels during pregnancy. Methods: We performed the ultrasound measurement of maternal Armellini space and preperitoneal space among 55 pregnant patients under 20 weeks in a low risk outpatient setting at south of Brazil and comparing with the maternal fasting glycemic levels. The pre-pregnant maternal body mass index (BMI, in Kg/m 2 ) was estimated with first pregnant weight measurement and height was measured during the case inclusion process. The fasting glucose used (mg/dl) was obtained in the pregnant booklet.
Results:
The mean age of pregnant women was 26yo (17 − 40yo), The mean pre-pregnancy BMI was 27,4 kg/m 2 (±6,8kg/m 2 ) and mean glycemic were 82.2mg/dl (±9,1mg/dl). The mean Armellini measurement was 41.4mm (±15.9mm) and mean preperitoneal measurement was 12.1mm (±5.4mm). We found a positive correlation between glycemic levels and the Armellini measurement (r = 0.381, p ∠ 0.05) controlling for pre-pregnancy body mass index. Preperitoneal space was not correlated with glycemic levels (r = -0.003, p= 0.984). Both measurements were correlated with BMI: the Armellini measurement presents r = 0.580; p∠ 0.001 and preperitoneal measurement with r = 0.491; p∠ 0.001. Conclusions: Even both measurements were correlated with BMI, however, only the Armellini space was correlated with fasting glycemic levels. VAT measurement trough ultrasound can be of clinical utility in the pregnancy, allowing early medical procedures for diabetes diagnosis and early treatment. However, there is a need for identifying its cut off which best predict the risk. Objectives: Increased early pregnancy visceral adipose tissue thickness has been associated with glucose intolerance, pre-eclampsia and preterm birth but it is not known whether it is independently associated with post-partum weight retention. The purpose of this study was to determine if visceral adipose tissue thickness, as measured by ultrasound in early pregnancy, is associated with sonographic measures of maternal adiposity at 6 weeks postpartum. Methods: A prospective cohort study of 97 pregnant women. Maternal visceral adiposity thickness (VAT), superficial adiposity thickness (SAT) and total adiposity thickness (TAT) were measured by ultrasound at 11 to 14 weeks' gestation and again 6 weeks postpartum. Associations between early pregnancy and postpartum measurements were adjusted for gestational weight gain (GWG), body mass index (BMI) and gestational diabetes.
Results: There was a significant correlation between VAT, SAT and TAT during the first trimester and 6 weeks postpartum, with an r of 0.57, 0.56 and 0.63, respectively. After controlling for BMI, GWG and gestational diabetes, adiposity tissue depth during the first trimester was independently associated with adiposity tissue depth at 6 weeks postpartum (p<0.001 for all three tissue measurements). Conclusions: First trimester adiposity contributes nearly 40% to residual postpartum adiposity even after adjustment for GWG, BMI and gestational diabetes. This information can help understand the determinants of post partum weight retention, a significant contributor to future obesity.
EP17.08
The association between maternal vitamin B12 insufficiency and obesity: a systematic review Methods: Inclusion criteria was body mass index (BMI) greater than or equal to 30 kg/m 2 , non diabetic, pregnant population. The outcome was vitamin B12 level measured at any gestational age. We considered observational studies, randomised control trials and case control studies. We searched Medline, Embase, CINAHL and The Cochrane Library database. Two reviewers independently extracted data from relevant studies. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) statement.
Results:
Of 366 articles identified, seven met inclusion criteria. Most studies were observational, with one case control study. There was consistent evidence linking maternal obesity with low vitamin B12 levels (defined as <150 pmol/L).
Most studies adjusted for potential confounders, such as maternal demographics, lifestyle factors, pregnancy related factors and hemodilution. BMI remained a significant negative predictor of low vitamin B12.
In the case control study, third trimester vitamin B12 insufficiency was associated with a 2.4 times increased odds of first trimester obesity.
Conclusions:
As the prevalence of maternal obesity is rapidly increasing, the implications of low vitamin B12 on maternal and fetal health need to be considered. Further longitudinal cohort studies are needed to understand the mechanisms between vitamin B12 and obesity, to identify any possible causal relationship and therefore potentially offer simple interventions to improve maternal and offspring health. Objectives: To quantify actograph output in healthy third trimester pregnancies and investigate this in relation to estimated fetal weight.
EP17.09
Methods: 42 women between 24 to 34 weeks of gestation underwent an ultrasound growth scan followed by a computerised cardiotocograph (CTG). Post capture analysis of the actograph recording was performed and expressed as a percentage of activity over time. The actograph output results were analysed in relation to estimated fetal weight (Hadlock) based on ultrasound and expressed as z score normalised for gestation.
Results: There was a significant association between actograph output recording and estimated fetal weight Z score (R = 0.546, p = <0.005). This activity was not related to estimated fetal weight.
Conclusions:
Fetal movements assessed by the actograph are associated with fetal size in relation to gestation. It is not the case that larger babies move more, however, as the relationship with actograph output related only to estimated fetal weight z score. Previous studies have suggested that optimal fetal size for perinatal survival is between the 80-90th centiles. Hence, average birthweight may not be associated with optimal fetal and perinatal health. If fetal movements are understood to be a marker of fetal health, then smaller babies that move less maybe at particular perinatal risk.
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Pregnancy outcome of presentation with reduced fetal movements (RFM) to day assessment unit Objectives: The perception of FM is a natural, symbolic involvement of the mother in the growth of a fetus, promoting maternal-fetal bonding. RFM has association with complications such as IUGR, fetal distress, stillbirth and admission to NICU. Monitoring of fetal movement is therefore a useful and inexpensive screening tool for fetal wellbeing. Perception of RFM is very subjective and affected by maternal factors such as raised BMI, maternal activities and maternal medications. Evaluation of the attendance with outcome of patients with RFM is essential for provision of holistic care. Methods: A retrospective study was carried out on sample of pts presenting to DAU of RBH Reading with RFM focusing on the following outcome; gestation of presentation (GP), gestation of delivery(GD), mode of delivery, APGAR score and cord gases. Results: 180 pt presented at DAU with RFM out of 924 pts' visitation over a 6-wk period.
61(6.6%) pts were followed up for the pregnancy outcome. % of Pt & GP:
• 20-26wks-(6.5%). 27-31wks-(26.2%). 32-36wks-(24.6%). 37-40wks-(21.3%) • % of Pt & GD;-• <30wks; -1.6% {EMCS}, • 31-36wks; -6.6%{1-SVD,2-FD,1-EMCS}, • 37-40wks; -42.6%{SVD-15, FD-6 C/section -5), • 40-42wks; -47.5%{SVD-15 FD-5 C/section-9}
Only one patient who presented at 29wks with emergency Caesarean section has both low APGAR and low arterial PH of 7.07venous 7.08 BE -11. Conclusions: Pt with RFM makes up 19.6% of presentations. Majority presented at 32-36wk (24.6%) follow by 37-40wks (21.3%). RFM < 30wks gestation which necessitates delivery is likely to result in EMCS with low APGAR and Blood Gases.
Pt with Hx of RFM that delivered between 31 -36wks have 75% chances of vaginal delivery (50% instrumental delivery) and 25% chance of Caesarean section. While those delivering between 37-40wks have 80% vaginal delivery chances and 19%-Caesarean section.
Pt delivering between 40-42wks have 31% chances of Caesarean section, 69% of Vagina delivery (17% instrumental delivery) This study has limitation of involvement of small number and variation in maternal perception of RFM.
This study also showed an association with maternal BMI and perception of RFM.
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Evaluation of self-testing of urine by patient during pregnancy F. Ajibade, S. Agwu
Obstetrics and Gynecology, Worcester Royal Hospital, Worcester, United Kingdom
Objectives: Testing of urine is important for diagnosis of pregnancy and monitoring of women health during antenatal period
